Can a popular diabetes drug help those with spinal cord injury?
NCT ID NCT06706284
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study tests whether semaglutide, a common diabetes drug, works well for people with spinal cord injury (SCI) who also have type 2 diabetes. SCI increases the risk of diabetes, but standard treatments may not work the same. The study will measure how the drug affects blood sugar control and insulin sensitivity in 50 adults with SCI.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health - Texas Diabetic Institute
RECRUITINGSan Antonio, Texas, 78207, United States
Contact
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
University of Texas Health Science Center at San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.